MED Alliance to Exhibit Portfolio at CHSS 2019
MED Alliance Solutions is excited to announce its attendance and exhibition at the Congenital Heart Surgeon’s Society (CHSS) 47th Annual Meeting in Chicago, Illinois from October 27-28. Cardiothoracic surgeons will attend to learn about the latest innovations in techniques and cardiothoracic surgery devices.
MED Alliance Solutions will display a wide portfolio of cardiothoracic devices from manufacturers Delacroix-Chevalier, Redax and Surge Cardiovascular. Stop by our booth to speak with our manufacturing partners and assisting sales team about the clinical impact, quality and cost savings our products offer.
Our cardiothoracic instruments are specially designed to enhance cardiothoracic surgery procedures and patient outcomes. Some notable products on display will include:
The Redax Spiral Drain facilitates performance with its unique helical design allowing complex positioning, enhanced drainage, patency and patient comfort.
Surge and replace with a statement: Surge Cardiovascular offers quality-based and affordable products in cardioplegia delivery systems and open-heart accessories such as femoral venous cannulae, antegrade cardioplegia cannulae and tourniquet sets.
Delacroix-Chevalier offers high-quality cardiothoracic instrumentation and retraction platforms enabling access, exposure and precision such as the SuperGrips, Carpentier Retractor and Casteneda Clamps.
MED Alliance Solutions and our manufacturing partners are committed to providing effective solutions for cardiothoracic surgeons. We look forward to meeting the members of the Congenital Heart Surgeon’s Society and showing attendees the unique benefits our devices allow.
If you are unable to attend CHSS 2019 and wish to learn more about these or other cardiothoracic surgical medical devices sold and distributed through MED Alliance, please contact 888-891-1200 or email us to be connected to the appropriate representative.
The most widely used method of delivering cardioplegia to the myocardium is via antegrade cardioplegia cannulae. Minimally invasive techniques, with Read more
36% of chest tubes clog or become completely occluded following surgery.[1] Occluded drains following any surgery can result in costly Read more
Discover our innovative cardiothoracic surgery devices during the 2024 Michigan Society of Thoracic & Cardiovascular Society Annual Meeting.
As cardiovascular surgeons embrace the difficulty of minimally invasive techniques, the innovative Delacroix-Chevalier MICS CABG platform empowers their success.
